Cells 2012, 1(4), 1246-1260; doi:10.3390/cells1041246
Review

Neovascularization in Tissue Engineering

1,2email and 1,2,* email
Received: 31 August 2012; in revised form: 8 November 2012 / Accepted: 5 December 2012 / Published: 11 December 2012
(This article belongs to the Special Issue Tissue and Organ Regeneration)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: A prerequisite for successful tissue engineering is adequate vascularization that would allow tissue engineering constructs to survive and grow. Angiogenic growth factors, alone and in combination, have been used to achieve this, and gene therapy has been used as a tool to enable sustained release of these angiogenic proteins. Cell-based therapy using endothelial cells and their precursors presents an alternative approach to tackling this challenge. These studies have occurred on a background of advancements in scaffold design and assays for assessing neovascularization. Finally, several studies have already attempted to translate research in neovascularization to clinical use in the blossoming field of therapeutic angiogenesis.
Keywords: neovascularization; angiogenesis; therapeutic angiogenesis; endothelial progenitor cells
PDF Full-text Download PDF Full-Text [205 KB, uploaded 11 December 2012 08:29 CET]

Export to BibTeX |
EndNote


MDPI and ACS Style

Chung, J.C.-Y.; Shum-Tim, D. Neovascularization in Tissue Engineering. Cells 2012, 1, 1246-1260.

AMA Style

Chung JC-Y, Shum-Tim D. Neovascularization in Tissue Engineering. Cells. 2012; 1(4):1246-1260.

Chicago/Turabian Style

Chung, Jennifer C.-Y.; Shum-Tim, Dominique. 2012. "Neovascularization in Tissue Engineering." Cells 1, no. 4: 1246-1260.

Cells EISSN 2073-4409 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert